Package 69238-1120-1

{"route": ["ORAL"], "spl_id": "b77a2557-2013-46ce-8d87-a25f17be5b89", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["d9b0ca6c-4c53-4f6e-918b-02a8c472a194"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69238-1120-1)", "package_ndc": "69238-1120-1", "marketing_start_date": "20170504"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69238-1120-5)", "package_ndc": "69238-1120-5", "marketing_start_date": "20170504"}], "brand_name": "Oxaprozin", "product_id": "69238-1120_b77a2557-2013-46ce-8d87-a25f17be5b89", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "69238-1120", "generic_name": "Oxaprozin", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA208633", "marketing_category": "ANDA", "marketing_start_date": "20170504", "listing_expiration_date": "20261231"}